Calamos Wealth Management’s CVS Health CVS Stock Holding History

Calamos Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$541K	Sell	7,531 -991	-12%	-$76.3K	0.02%	289
2025 Q4	$676K	Buy	8,522 +1,992	+31%	+$157K	0.02%	239
2025 Q3	$492K	Buy	6,530 +1,832	+39%	+$126K	0.02%	269
2025 Q2	$324K	Buy	+4,698	New	+$308K	0.01%	279
2023 Q1	–	Sell	-2,738	Closed	-$255K	–	316
2022 Q4	$255K	Sell	2,738 -21	-0.8%	-$2.03K	0.02%	278
2022 Q3	$263K	Buy	2,759 +388	+16%	+$38.4K	0.02%	268
2022 Q2	$220K	Sell	2,371 -42	-2%	-$4.1K	0.02%	294
2022 Q1	$244K	Buy	+2,413	New	+$253K	0.02%	302
2016 Q4	–	Sell	-2,317	Closed	-$206K	–	226
2016 Q3	$206K	Buy	+2,317	New	+$219K	0.04%	190

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Calamos Wealth Management's CVS Position: Q1 2026 in Review

Calamos Wealth Management reduced its CVS Health (CVS) stake by 12% in Q1 2026, selling an estimated $76.3K and leaving 7,531 shares worth $541K. The position accounts for 0.02% of the portfolio, ranked #289.

Calamos Wealth Management first reported a position in CVS in Q3 2016 and has held it in 9 quarters since. The position peaked at $676K in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Calamos Wealth Management held 7,531 shares of CVS Health worth $541K as of Q1 2026.
Calamos Wealth Management sold 991 CVS Health shares in Q1 2026, an estimated $76.3K.
CVS Health made up 0.02% of Calamos Wealth Management's portfolio in Q1 2026, its #289 holding.
Calamos Wealth Management first reported a position in CVS Health in Q3 2016 and has held it in 9 quarters since.
Calamos Wealth Management's CVS Health position peaked at $676K in Q4 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Calamos Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.